This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, X.-S.
Right arrow Articles by Arvin, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, X.-S.
Right arrow Articles by Arvin, A. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Flu

 Previous Article  |  Next Article 

Journal of Virology, December 2006, p. 11756-11766, Vol. 80, No. 23
0022-538X/06/$08.00+0     doi:10.1128/JVI.01460-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines{triangledown}

Xiao-Song He,1,2* Tyson H. Holmes,3 Caiqiu Zhang,1,2 Kutubuddin Mahmood,4 George W. Kemble,4 David B. Lewis,5 Cornelia L. Dekker,5 Harry B. Greenberg,1,2,6,{dagger} and Ann M. Arvin5,{dagger}

Departments of Medicine,1 Health Research and Policy (Biostatistics),3 Pediatrics,5 Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305,6 VA Palo Alto Health Care System, Palo Alto, California 94304,2 Medimmune Vaccines, Mountain View, California 943034

Received 11 July 2006/ Accepted 5 September 2006

The patterns of cellular immune responses induced by live attenuated influenza vaccine (LAIV) versus those of the trivalent inactivated influenza vaccine (TIV) have not been studied extensively, especially in children. The goals of this study were to evaluate the effects of TIV and LAIV immunization on cellular immunity to live influenza A virus in children and adults and to explore factors associated with variations in responses to influenza vaccines among individuals. A gamma interferon (IFN-{gamma}) flow cytometry assay was used to measure IFN-{gamma}-producing (IFN-{gamma}+) NK and T cells in peripheral blood mononuclear cell cultures stimulated with a live influenza A virus strain before and after LAIV or TIV immunization of children and adults. The mean percentages of influenza A virus-specific IFN-{gamma}+ CD4 and CD8 T cells increased significantly after LAIV, but not TIV, immunization in children aged 5 to 9 years. No increases in the mean levels of influenza A virus-reactive IFN-{gamma}+ T cells and NK cells were observed in adults given LAIV or TIV. TIV induced a significant increase in influenza A virus-reactive T cells in 6-month- to 4-year-old children; LAIV was not evaluated in this age group. The postvaccination changes (n-fold) in the percentages of influenza A virus-reactive IFN-{gamma}+ T and NK cells in adults were highly variable and correlated inversely with the prevaccination percentages, in particular with that of the CD56dim NK cell subset. In conclusion, our findings identify age, type of vaccine, and prevaccination levels of immune reactivity to influenza A virus as factors significantly associated with the magnitude of cellular immune responses to influenza vaccines.


* Corresponding author. Mailing address: VA Palo Alto Health Care System 154C, 3801 Miranda Avenue, Palo Alto, CA 94304. Phone: (650) 493-5000, ext. 66135. Fax: (650) 852-3259. E-mail: xiaosong{at}stanford.edu.

{triangledown} Published ahead of print on 13 September 2006.

{dagger} H.B.G. and A.M.A. contributed equally to this work.


Journal of Virology, December 2006, p. 11756-11766, Vol. 80, No. 23
0022-538X/06/$08.00+0     doi:10.1128/JVI.01460-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Zhang, W., Li, W., Li, Y., Li, H., Wang, B., Wang, F., Zhu, Y., Jiang, Z., Zhong, L., Li, M. (2009). Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes. J Med Microbiol 58: 845-854 [Abstract] [Full Text]  
  • Teijaro, J. R., Njau, M. N., Verhoeven, D., Chandran, S., Nadler, S. G., Hasday, J., Farber, D. L. (2009). Costimulation Modulation Uncouples Protection from Immunopathology in Memory T Cell Responses to Influenza Virus. J. Immunol. 182: 6834-6843 [Abstract] [Full Text]  
  • Yu, C. I., Gallegos, M., Marches, F., Zurawski, G., Ramilo, O., Garcia-Sastre, A., Banchereau, J., Palucka, A. K. (2008). Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood 112: 3671-3678 [Abstract] [Full Text]  
  • Terajima, M., Cruz, J., Leporati, A. M., Orphin, L., Babon, J. A. B., Co, M. D. T., Pazoles, P., Jameson, J., Ennis, F. A. (2008). Influenza A Virus Matrix Protein 1-Specific Human CD8+ T-Cell Response Induced in Trivalent Inactivated Vaccine Recipients. J. Virol. 82: 9283-9287 [Abstract] [Full Text]  
  • Forrest, B. D., Pride, M. W., Dunning, A. J., Capeding, M. R. Z., Chotpitayasunondh, T., Tam, J. S., Rappaport, R., Eldridge, J. H., Gruber, W. C. (2008). Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children. CVI 15: 1042-1053 [Abstract] [Full Text]  
  • Long, B. R., Michaelsson, J., Loo, C. P., Ballan, W. M., Vu, B.-A. N., Hecht, F. M., Lanier, L. L., Chapman, J. M., Nixon, D. F. (2008). Elevated Frequency of Gamma Interferon-Producing NK Cells in Healthy Adults Vaccinated against Influenza Virus. CVI 15: 120-130 [Abstract] [Full Text]  
  • Sasaki, S., Jaimes, M. C., Holmes, T. H., Dekker, C. L., Mahmood, K., Kemble, G. W., Arvin, A. M., Greenberg, H. B. (2007). Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines. J. Virol. 81: 215-228 [Abstract] [Full Text]